Requite Prostate Cohort: Validating Clinical/Dosimetric/Genetic Risk Factors for Late Urinary Toxicity
Volume: 105, Issue: 1, Pages: E317 - E318
Published: Sep 1, 2019
Abstract
REQUITE is an international, prospective cohort study, which recruited lung, breast and prostate cancer (PCa) patients (pts) in 8 countries (April 2014-March 2017). The aim is multinational validation of clinical/dosimetric/genetic risk factors for prediction of late toxicity following radiotherapy (RT). We present preliminary results on validation of such features for late urinary (UR) toxicity (tox) after external beam RT (EBRT) for PCa. 1808...
Paper Details
Title
Requite Prostate Cohort: Validating Clinical/Dosimetric/Genetic Risk Factors for Late Urinary Toxicity
Published Date
Sep 1, 2019
Volume
105
Issue
1
Pages
E317 - E318
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History